In an effort to develop anticancer agents, a series of Mannich bases were prepared by Mannich reaction. When one biologically active molecule is linked to another, the resultant molecule generally has increased potency. Hence two pharmacophores, i.e. quinazoline ring and amine moiety are fused to obtain highly potent, more specific and less toxic agent. In the present study, synthesis of novel quinazolin-4(3H)-one derivatives by condensation of appropriate quinazolines with various psubstituted primary amines in presence of glacial acetic acid and ethanol at room temperature (Mannich reaction). Synthesized compounds were characterized; both analytical and spectral data (UV, IR, GC-MS, 1 H NMR) of all derivatives were in full agreement with proposed structures. All the derivatives were tested for their anti-tumor activity by two in vitro studies like Brine shrimp Lethality assay and Trypan blue exclusion assay.
Introduction
The search for new anticancer agent is one of the most challenging tasks to the medicinal chemist. Heterocyclic compounds are biologically important class of compounds. This prompted us to synthesize hybrid analogues of two pharmacophores viz., quinazolinone and Mannich bases. In search for new bioactive potent molecule, it was thought worth while to incorporate some additional heterocyclic moieties in the quinazoline nucleus and study their biological and pharmacological activity, the extensive review of literature revealed the compounds have anticancer activity [1] [2] [3] [4] . The earliest uses in the pharmaceutical area for quinazoline are anti viral 5 , anti parkinsonism 6,7, anti microbial [8] [9] [10] [11] , anti inflammatory 12 , bronchodilator 13 , anti hypertensive 14 . Encouraged by the above observations from the literature, it was planned to suitably incorporate the Mannich bases in to quinazolinone and to synthesize a better drug with less toxicity to the host, it is observed that chemical modification not only alters physiochemical properties but also pharmacological properties.
Experimental
All the chemicals used in the synthesis were of Laboratory grade. The melting points were taken in open capillaries in liquid paraffin and are uncorrected. To monitor the progress of reactions and to establish the identity and purity of reactants and products, thin layer chromatography was performed on aluminium slides coated with silica gel 60, using appropriate solvent systems and the spots were visualized under ultra-violet light. IR spectra were recorded in KBr on a Shimadzu FTIR 8310 spectrometer. PMR spectrum on AMX 400 (400 MHz) instrument (chemical shift in δ ppm) using TMS as internal standard. Mass spectra were recorded in Shimadzu GC-MSQP5050. The structures of the synthesized compounds were confirmed by spectral analysis.
General procedure for the synthesis of Scheme-1 products
Step-1: Synthesis of 2-(4-substituted phenyl) quinazolin-4(3H)-one (QZ 1-4)
To the solution of 2-aminobenzamide (0.01 moles) and respective p-substituted benzaldehyde (0.01 moles) in 10 mL of ethanol, catalytic amount of acetic acid was added. The solution was refluxed and the progress of the reaction was monitored using TLC 15% ethyl acetate in chloroform (Solvent system: Ethyl acetate-Chloroform: 15:85). After completion of reaction, the reaction mixture was cooled to room temperature and the product obtained was filtered, washed with water and crystallized from absolute ethanol and chloroform (50:50). The physical data of the compounds synthesized were in confirmation with the literature value. The physical data of the compounds synthesized are given in Table 1 . [15] [16] [17] To the solution of QZ 1-4 (0.01 moles) and respective p-substituted primary amines (0.01 moles) in 5 mL of glacial acetic acid, formaldehyde solution 30% (0.05 moles) was added. The solution was refluxed and the progress of the reaction is monitored using TLC Solvent system: Ethyl acetate-chloroform: 15:85. After completion of reaction, the reaction mixture was cooled and immediately poured to crushed ice. The product obtained was filtered, washed with methanol and crystallized from absolute ethanol and chloroform (50:50). 
2-(4-Chloro phenyl)-3-[(phenyl amino) methyl] quinazolin-4(3H)-one (QZ1M1)
Yield
2-(4-Chloro phenyl)-3-[(p-tolyl amino) methyl] quinazolin-4(3H)-one (QZ1M2)
2-(4-Chloro phenyl)-3-[(p-tolyl amino) methyl] quinazolin-4(3H)-one (QZ1M3)
2-(4-Fluoro phenyl)-3-[(phenyl amino) methyl] quinazolin-4(3H)-one (QZ2M1)
2-(4-Fluoro phenyl)-3-[(p-tolyl amino) methyl] quinazolin-4(3H)-one (QZ2M2)
2-(4-Fluoro phenyl)-3-[(p-methoxy phenyl amino) methyl] quinazolin-4(3H)-one (QZ2M3)
3-[(Phenyl amino) methyl]2-p-tolyl quinazolin-4(3H)-one (QZ3M1)
3-[(4-Chlorophenyl amino) methyl] 2-p-tolyl quinazolin-4(3H)-one (QZ3M4)
3-[(4-Bromo phenyl amino) methyl] 2-p-tolyl quinazolin-4(3H)-one (QZ3M5)
2-(4-Methoxy phenyl)-3-[(phenyl amino) methyl] quinazolin-4(3H)-one (QZ4M1)
3-(4-Chloro phenyl amino methyl) -2-(p-methoxy phenyl) quinazolin-4(3H)-one (QZ4M4)
3-(4-Bromo phenyl amino) methyl) -2-(p-methoxy phenyl) quinazolin-4(3H)-one (QZ4M5)
Results and Discussion

Anti-tumor activity
Anti-tumor activity was evaluated by two methods viz., Brine shrimp lethality bioassay and Trypan blue exclusion method.
Brine shrimp lethality bioassay
This method was developed by Mayer et al 18 . Drug samples were prepared by dissolving 10 mg of derivative in 10 mL of ethanol. Nauplli were drawn in a pipette along with water and ten shrimps were transferred to each sample vial after they were counted in the stem of pipette against lighted background. The artificial sea water was added to each vial to make up to 5 mL, a drop of dry yeast suspension (3 mg in 5 mL seawater) was added to each vial as food for shrimps 3 . The vials were maintained under illumination. After 24 hours, survivors were counted by using 3X magnifying glass and the percent deaths, ED 50 values are calculated by using +ve control K 2 Cr 2 O 7 and -ve control ethyl alcohol and the results are shown in Table 2 and Figure 1 . Composition of the artificial sea water is given in Table 3 . A suspension of 1x10 6 cells was prepared in phosphate buffer saline (PBS its composition was shown in Table 4 ) and the viability of the cell was checked by counting with a haemocytometer. DMSO was taken as solvent as solubilizing agent and its concentration was not allowed to go beyond 0.1% (v/v) of total volume. Various concentrations of the derivative viz., 10 µg, 25 µg and 50 µg was taken in a clean test tube added 100 µL of the EAC cells final volume was adjusted with buffer up to 1 mL respectively. All the test tubes were incubated at 37 0 C for 3 h along with control and solvent control. After incubation, 100 µL of 4% tryphan blue was added to each test tube. The alive cells (with out stain) and dead cells (stained) were calculated and checked for the percentage cytotoxicity 19 . The % cytotoxicity and IC 50 of synthesized compounds at different concentrations are given in Table 5 . IC 50 of synthesized compounds against EAC Cells was graphically represented in Figure 2 .
% Cytotoxicity = (T dead -C dead ) / T total x 100 Where, T dead = number of dead cells in the drug treated tube, C dead = number of dead cells in the control tube, T total = number of dead and alive cells in the drug treated tube 
Conclusion
The synthesized derivatives were characterized and identified on the basis of physical and spectral data. The derivatives were tested for in vitro cytotoxic potential using brine shrimp lethality bioassay and tryphan blue exclusion method. Since all the compounds are active, investigation proceeded for tryphan blue exclusion method using EAC cells. All the synthesized compounds were screened for their cytotoxicity on EAC cells at 10, 25 and 50 µg/mL. The tryphan blue exclusion technique indicates that the IC 50 of the standard drug cisplatin is 191.16 and that of control was 500.83. All the compounds displayed cell necrosis above 10 µg/mL. It reveals that cell necrosis is the main reason for the cell death. In some cases morphological changes in cells were found. It is suspected to be cell apoptosis, which might be the reason for cell death. All the synthesized drugs showed the activity. But promising anti-tumor activity was shown by compounds QZ1M2, QZ2M3, QZ3M4 and QZ4M which might be attributed to the presence of electron with drawing and donating substitution at para or 4 th position of the phenyl ring which is at position 2 of quinazolinone ring and in Mannich bases. Thus, the synthesized quinazolinone Mannich compounds containing halogens were more lipophilic than others as per the value. As the compounds are lipophilic in nature they can display good permeability through the phospholipids membranes and so a better activity can be expected.
